| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a4a1e9593b4743b897481773bc06c91 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate |
1997-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6dfed31137f6ad1f991271cec069248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4916924de211b80f295ea2f07777f9 |
| publicationDate |
2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1382331-B1 |
| titleOfInvention |
A pharmaceutical tablet characterized by showing a high volume increase when coming into contact with biological fluids |
| abstract |
A description is given of a pharmaceutical form for oral administration consisting of a two- or three-layers tablet, wherein at least one layer can rapidly swell by contact with biological and/or aqueous fluids, said swelling resulting in a considerable increase in the tablet volume. Said phenomenon determines a prolonged residence of the pharmaceutical form at the gastric level and therefore allows a slow release of the active ingredient from said pharmaceutical form to the stomach and/or the first tract of the intestine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013310455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421178-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013310456-A1 |
| priorityDate |
1996-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |